Frankfurt - Delayed Quote EUR
Madrigal Pharmaceuticals, Inc. (YDO1.F)
272.00
+7.50
+(2.84%)
At close: 9:55:02 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 13 | 13 | 15 | 13 |
Avg. Estimate | 113.15M | 138.68M | 589.64M | 1.04B |
Low Estimate | 96.82M | 119.42M | 487.42M | 751.1M |
High Estimate | 132M | 158M | 685.3M | 1.33B |
Year Ago Sales | -- | 14.64M | 180.13M | 589.64M |
Sales Growth (year/est) | 0.00% | 847.38% | 227.34% | 76.52% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
YDO1.F | -- | -- | -- | -- |
S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
Maintains | Citigroup: Buy to Buy | 2/27/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 1/14/2025 |
Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/10/2025 |
Reiterates | Cantor Fitzgerald: Neutral | 11/20/2024 |
Maintains | B. Riley Securities: Neutral to Neutral | 11/5/2024 |